• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Hanger Inc.

    10/3/22 1:21:39 PM ET
    $HNGR
    Medical Specialities
    Health Care
    Get the next $HNGR alert in real time by email
    S-8 POS 1 a22-27048_1s8pos.htm S-8 POS

     

    As filed with the Securities and Exchange Commission on October 3, 2022

     

    Registration No. 333-228488

    Registration No. 333-231610

    Registration No. 333-265148

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-228488

    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-231610

    POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-265148

    UNDER

    THE SECURITIES ACT OF 1933

     


     

    Hanger, Inc.

    (Exact name of registrant as specified in its charter)

     


     

    Delaware

     

    84-0904275

    (State or other jurisdiction of
    incorporation or organization)

     

    (I.R.S. Employer
    Identification No.)

     

    10910 Domain Drive, Suite 300

    Austin, Texas 78758

    (Address of principal executive offices)(Zip code)

     


     

    Hanger, Inc. 2016 Omnibus Incentive Plan

    Hanger, Inc. Special Equity Plan
    Hanger, Inc. 2019 Omnibus Incentive Plan
    Hanger, Inc. 2022 Omnibus Incentive Plan

    (Full title of the plan)

     


     

     

     

    with a copy to:

    Thomas E. Hartman
    Senior Vice President, Secretary and
    General Counsel
    10910 Domain Drive, Suite 300

    Austin, TX 78758
    (512) 777-3800

     

    Jessica S. Lochmann
    Foley & Lardner LLP
    777 East Wisconsin Avenue
    Milwaukee, Wisconsin 53202-5306
    (414) 271-2400

    (Telephone number, including area code, of agent for service)

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer

    x

    Accelerated filer

    o

    Non-accelerated filer

    o

    Smaller reporting company

    o

     

     

    Emerging growth company

    o

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  o

     

     

     


     

    DEREGISTRATION OF SECURITIES

     

    Hanger, Inc. (the “Registrant”) is filing these post-effective amendments (each, a “Post-Effective Amendment” and, together, the “Post-Effective Amendments”) to the following Registration Statements on Form S-8 (each, a “Registration Statement” and, together, the “Registration Statements”), which have been previously filed with the Securities and Exchange Commission (the “SEC”), to deregister any and all shares of the Registrant’s common stock, par value $0.01 per share (“Common Stock”), registered but unsold or otherwise unissued under each such Registration Statement as of the date hereof:

     

    1.              Registration Statement No. 333-228488, filed with the SEC on November 20, 2018, registering (i) 2,404,502 shares of Common Stock for issuance under the Hanger, Inc. 2016 Omnibus Incentive Plan (the “2016 Plan”) and (ii) 1,227,363 shares of Common Stock for issuance under the Hanger, Inc. Special Equity Plan;

     

    2.              Registration Statement No. 333-231610, filed with the SEC on May 20, 2019, registering (i) 2,025,000 shares of Common Stock for issuance under the Hanger, Inc. 2019 Omnibus Incentive Plan (the “2019 Plan”), (ii) 242,936 shares of Common Stock that remained available for future grants under the 2016 Plan when the 2019 Plan was approved and that, under the terms of the 2019 Plan, became available for future grants under the 2019 Plan, and (iii) 348,025 shares of Common Stock that were subject to outstanding awards under the 2016 Plan at the effective time of the 2019 Plan but that were expected to become available for grant under the 2019 Plan as a result of future forfeitures; and

     

    3.              Registration Statement No. 333-265148, filed with the SEC on May 23, 2022, registering (i) 1,960,000 shares of Common Stock pursuant to the Hanger, Inc. 2022 Omnibus Incentive Plan (the “2022 Plan”), (ii) 412,867 shares of Common Stock that remained available for future grants under the 2019 Plan at the effective time of the 2022 Plan, and (iii) 414,392 shares of Common Stock that were subject to outstanding awards under the 2019 Plan at the effective time of the 2022 Plan but that were expected to become available for grant under the 2022 Plan as a result of future forfeitures.

     

    On October 3, 2022, the Registrant completed its previously announced merger (the “Merger”) with Hero Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Hero Parent, Inc., a Delaware corporation (“Parent”), pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 21, 2022, by and among the Registrant, Parent and Merger Sub (the “Merger Agreement”). The Registrant was the surviving corporation in the Merger and, as a result of the Merger, has become a wholly owned subsidiary of Parent. In connection therewith, each share of Common Stock issued and outstanding immediately prior to the effective time of the Merger (other than (i) shares held by Hanger as treasury stock or held directly by Parent or Merger Sub or any direct or indirect wholly owned subsidiary of Hanger, Parent or Merger Sub, (ii) shares of Common Stock held by stockholders who have not voted in favor of the adoption and approval of the Merger Agreement, including the Merger, or consented thereto in writing and who have properly exercised and validly perfected appraisal rights for such shares in accordance with, and who have complied with, Section 262 of the Delaware General Corporation Law and (iii) shares of Common Stock held by certain members of the Registrant’s management team that were exchanged for equity interests in an affiliate of Parent) was automatically converted into the right to receive cash in an amount equal to $18.75 per share, without interest, subject to any required withholding of taxes.

     

    As a result of the Merger, the offerings contemplated by the Registration Statements have been terminated as of the effective time of the Merger on October 3, 2022. In accordance with the undertakings contained in each Registration Statement to remove from registration, by means of a post-effective amendment, any and all securities registered but unsold at the termination of such offerings, the Registrant hereby removes from registration any and all securities registered but unsold under the Registration Statements as of the effective time of the Merger on October 3, 2022. Each Registration Statement is hereby amended, as appropriate, to reflect the deregistration of such securities.

     

    2


     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Austin, State of Texas, on October 3, 2022.

     

     

    HANGER, INC.

     

     

     

     

     

     

    By:

    /s/ Thomas E. Hartman

     

     

    Name:

    Thomas E. Hartman

     

     

    Title:

    Senior Vice President, General Counsel and Secretary

     

    No other person is required to sign the Post-Effective Amendments to the Registration Statements in reliance upon Rule 478 under the Securities Act of 1933, as amended.

     

    3


    Get the next $HNGR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HNGR

    DatePrice TargetRatingAnalyst
    7/25/2022$24.00 → $18.75Buy → Hold
    Jefferies
    More analyst ratings

    $HNGR
    Financials

    Live finance-specific insights

    See more
    • Hanger Reports Second Quarter 2022 Financial Results

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended June 30, 2022. Financial Highlights Net revenues were $312.0 million for the three months ended June 30, 2022, compared to $280.8 million for the same period in 2021, reflecting growth of 11.1 percent. Patient Care same clinic revenue growth per day was 6.2 percent during the period. Net income was $10.1 million for the three months ended June 30, 2022, compared to $10.2 million for the same period in 2021. Income from operations was $20.8 million for the quarter compared to $20.1 million for

      8/8/22 4:05:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger, Inc. Announces Definitive Agreement to be Acquired by Patient Square Capital for $18.75 Per Share in Cash

      Total Enterprise Value of Approximately $1.25 Billion Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, which has been unanimously approved by Hanger's Board of Directors, Hanger stockholders will receive $18.75 in cash per share, representing an approximately 29% premium to the 30 calendar day volume-weighted average price (VWAP) ending July 20, 2022, and a total enterprise value of approximately $1.25 billion. Upon completion of the transaction,

      7/21/22 4:13:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger Announces Date of 2022 Second Quarter Earnings Release and Conference Call

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced it will report its financial results for the second quarter and six months ended June 30, 2022 after the stock market closes on Monday, August 8, 2022. Hanger's management team will host a conference call to discuss the second quarter 2022 financial results the following morning on Tuesday, August 9, 2022 at 8:30 a.m. Eastern time. To participate in the Company's live conference call, please dial (844) 200-6205 or +1 (929) 526-1599 for international participants and reference access code 020458. A live webcast, replay of the call and earnings release, will be availa

      7/7/22 8:00:00 AM ET
      $HNGR
      Medical Specialities
      Health Care

    $HNGR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Sullivan Kathryn M returned $1,162,988 worth of shares to the company (62,026 units at $18.75), closing all direct ownership in the company

      4 - HANGER, INC. (0000722723) (Issuer)

      10/4/22 5:25:47 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form 4: Jones Mark M returned $386,138 worth of shares to the company (20,594 units at $18.75), closing all direct ownership in the company

      4 - HANGER, INC. (0000722723) (Issuer)

      10/4/22 5:21:56 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form 4: Pettingill Richard returned $1,465,031 worth of shares to the company (78,135 units at $18.75), closing all direct ownership in the company

      4 - HANGER, INC. (0000722723) (Issuer)

      10/4/22 5:21:57 PM ET
      $HNGR
      Medical Specialities
      Health Care

    $HNGR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hanger, Inc. Completes Acquisition by Patient Square Capital

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on July 21, 2022, and Hanger's stockholders approved the transaction at a Special Meeting of Stockholders held on September 30, 2022. As a result of the completion of the acquisition, Hanger stockholders will receive $18.75 in cash per share of common stock, and Hanger's common stock will no longer be traded on the New York Stock Exchange (NYSE). Wit

      10/3/22 12:30:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Hanger, Inc. Stockholders Approve Acquisition by Patient Square Capital

      Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced that its stockholders approved at a special meeting the acquisition of Hanger by Patient Square Capital, a leading dedicated health care investment firm. Vinit Asar, Hanger's President and Chief Executive Officer said, "I would like to express my gratitude to the Hanger stockholders for their support today, and throughout this transaction process. The Hanger team is excited about this partnership with Patient Square Capital, and beginning our next chapter as a private company. We believe this collaboration will enable us to accelerate our growth and enhance our

      9/30/22 4:05:00 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • Frontier Communications Set to Join S&P MidCap 400; Hain Celestial Group to Join S&P SmallCap 600

      NEW YORK, Sept. 27, 2022 /PRNewswire/ -- Frontier Communications Parent Inc. (NASD: FYBR) will replace The Hain Celestial Group Inc. (NASD:HAIN) in the S&P Midcap 400 and The Hain Celestial Group will replace Hanger Inc. (NYSE:HNGR) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, October 3. Patient Square Capital, LP. is acquiring Hanger in a deal expected to be completed soon pending final closing conditions. The Hain Celestial Group is more representative of the small-cap market space. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Se

      9/27/22 6:16:00 PM ET
      $FYBR
      $HAIN
      $HNGR
      $SPGI
      Telecommunications Equipment
      Telecommunications
      Packaged Foods
      Consumer Staples

    $HNGR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hanger downgraded by Jefferies with a new price target

      Jefferies downgraded Hanger from Buy to Hold and set a new price target of $18.75 from $24.00 previously

      7/25/22 7:27:44 AM ET
      $HNGR
      Medical Specialities
      Health Care

    $HNGR
    Leadership Updates

    Live Leadership Updates

    See more
    • Evolent Health Appoints Seth R. Frank as Vice President, Investor Relations

      WASHINGTON, Dec. 1, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Seth R. Frank has joined the company as Vice President, Investor Relations, effective immediately. Reporting to John Johnson, Evolent's Chief Financial Officer, Seth will lead Evolent's investor relations (IR) strategy and oversee its relationships with the investment community. "Seth provides a demonstrated track record of proactive, finance-driven leadership in health care investor relations to Evolent," said Evolent Health Chief Financial Officer John Johnson. "He brings long-ter

      12/1/21 8:00:00 AM ET
      $EVH
      $HNGR
      $MDRX
      Other Consumer Services
      Consumer Discretionary
      Medical Specialities
      Health Care

    $HNGR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Hanger Inc. (Amendment)

      SC 13G/A - HANGER, INC. (0000722723) (Subject)

      11/8/22 11:20:47 AM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Hanger Inc. (Amendment)

      SC 13G/A - HANGER, INC. (0000722723) (Subject)

      8/10/22 2:56:04 PM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by Hanger Inc. (Amendment)

      SC 13G/A - HANGER, INC. (0000722723) (Subject)

      8/8/22 10:36:46 AM ET
      $HNGR
      Medical Specialities
      Health Care

    $HNGR
    SEC Filings

    See more
    • SEC Form 15-12G filed by Hanger Inc.

      15-12G - HANGER, INC. (0000722723) (Filer)

      10/13/22 9:00:25 AM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form EFFECT filed by Hanger Inc.

      EFFECT - HANGER, INC. (0000722723) (Filer)

      10/7/22 12:15:11 AM ET
      $HNGR
      Medical Specialities
      Health Care
    • SEC Form S-8 POS filed by Hanger Inc.

      S-8 POS - HANGER, INC. (0000722723) (Filer)

      10/3/22 1:29:11 PM ET
      $HNGR
      Medical Specialities
      Health Care